Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanish Davis

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Perspectives in Clinical Research|November 10, 2025
ICH GCP E6 has arrived: Are we ready?Sanish Davis
Perspectives in Clinical Research|November 11, 2021
Role of investigational new drug committees in propelling the drug development ecosystem in IndiaSanish Davis
Perspectives in Clinical Research|March 11, 2020
Embedding good clinical practice into investigator-initiated studies or trialsSanish Davis
Perspectives in Clinical Research|November 8, 2017
Clinical trials and healthcare needs in India: A difficult balancing act but opportunities abound!Sanish Davis
Perspectives in Clinical Research|March 13, 2023
Declaration of Helsinki: Can it still serve as a North star for ethics in regulatory trials?Sanish Davis
Perspectives in Clinical Research|August 14, 2024
Clinical trial footprint in BRICS: Improvements seen but needs further affirmative actionSanish Davis
Perspectives in Clinical Research|June 5, 2018
Monitoring of approved studies: A difficult tightrope walk by Ethics CommitteesSanish Davis
Perspectives in Clinical Research|February 16, 2026
Renaissance of Phase I trials in India: Lessons from global trials and tribulations of TGN1412Arun Bhatt, Sanish Davis
Perspectives in Clinical Research|October 9, 2020
Challenges and opportunities for sponsors in conducting clinical trials during a pandemicSanish Davis, Seema Pai
Perspectives in Clinical Research|January 27, 2025
Declaration of Helsinki 2024: Too much too late?Deepa Chodankar, Arun Bhatt, Sanish Davis
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Perspectives in Clinical Research|November 10, 2025
ICH GCP E6 has arrived: Are we ready?Sanish Davis
Perspectives in Clinical Research|November 11, 2021
Role of investigational new drug committees in propelling the drug development ecosystem in IndiaSanish Davis
Perspectives in Clinical Research|March 11, 2020
Embedding good clinical practice into investigator-initiated studies or trialsSanish Davis
Perspectives in Clinical Research|November 8, 2017
Clinical trials and healthcare needs in India: A difficult balancing act but opportunities abound!Sanish Davis
Perspectives in Clinical Research|March 13, 2023
Declaration of Helsinki: Can it still serve as a North star for ethics in regulatory trials?Sanish Davis
Perspectives in Clinical Research|August 14, 2024
Clinical trial footprint in BRICS: Improvements seen but needs further affirmative actionSanish Davis
Perspectives in Clinical Research|June 5, 2018
Monitoring of approved studies: A difficult tightrope walk by Ethics CommitteesSanish Davis
Perspectives in Clinical Research|February 16, 2026
Renaissance of Phase I trials in India: Lessons from global trials and tribulations of TGN1412Arun Bhatt, Sanish Davis
Perspectives in Clinical Research|October 9, 2020
Challenges and opportunities for sponsors in conducting clinical trials during a pandemicSanish Davis, Seema Pai
Perspectives in Clinical Research|January 27, 2025
Declaration of Helsinki 2024: Too much too late?Deepa Chodankar, Arun Bhatt, Sanish Davis
Pageof 2